… ProQR Appoints Theresa Heggie as Chief Commercial Officer … (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through the … brings a wealth of commercial and leadership skills to ProQR, having built commercial organizations and successfully …
… ProQR to Present at Upcoming SVB Leerink Conference LEIDEN, … will be accessible from the “Investors & Media” section of ProQR’s website ( www.proqr.com ) under “ Events ”. Archived webcasts will be …
… ProQR Announces Presentations at the OTS Annual Meeting … on QR-110 clinical data in LCA10 David Rodman, MD, EVP of R&D of ProQR, will give a presentation on the recent clinical data …
… ProQR Announces First Quarter 2024 Operating and Financial … & CAMBRIDGE, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company … expression of the protein. A strong correlation (R 2 = 0.51) is reported between editing levels of NTCP and …
… ProQR Announces Year End 2023 Operating and Financial Results … (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through … said Daniel A. de Boer, Chief Executive Officer of ProQR. “We announced our initial pipeline programs, AX-0810 …
… ProQR Announces First Quarter 2023 Operating and Financial … & CAMBRIDGE, Mass., May 16, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company … 31, 2023, and provided a business update. “During our R&D event in Q1, we provided a comprehensive update on how …
… ProQR Announces Results for the Second Quarter of 2017 Key … in need,“ said Daniel de Boer, Chief Executive Officer of ProQR. “We have made significant progress in all of our … the Axiomer ® platform technology we announced at our R&D day. I’m proud of our scientific team to have invented …
… ProQR Announces Third Quarter 2022 Operating and Financial … to be disclosed in early 2023 with Analyst and Investor R&D event to be held in Q1 2023 Management Team appointments … & CAMBRIDGE, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a …
… ProQR Announces Year End 2024 Operating and Financial Results … (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through … Daniel A. de Boer, Founder and Chief Executive Officer of ProQR. “With up to four clinical trial data readouts …